Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Case report · 2013 Review article · 2013 Monoclonal biologics in acute myeloid leukemia aml) therapy: translational strategies, policy, regulation and stakeholder engagement
Over 300 innovative biologic products have been tested for more than 200
Editorial · 30 Nov 2012 Targeting Epigenetic Mechanism as the Novel AML Therapy
Conference abstract Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia
Background: Acute myeloid leukemia (AML) is the second-most common form of leukemia in children. Aberrant DNA methylation patterns are a characteristic feature of AML. GATA4 has been suggested ... types of human cancers…
Review article · 26 May 2025 Acute Myelogenous Leukemia: Pathogenesis, Modern Therapies, and Future Directions
Acute Myelogenous Leukemia (AML) is an aggressive hematologic malignancy characterized by clonal proliferation of myeloid precursors with impaired differentiation. This review provides a comprehensive overview of AML…
Research article · 9 Aug 2021 Correlation of cyto-morphology with flow cytometric immunophenotyping in acute leukemia's: A comparative study
morphology, of these 200 cases, 134(67%) were classified as Acute Myeloid Leukemia (AML) and 50 were classified as Acute Lymphocytic Leukemia (ALL). Sixteen cases remained unclassified by morphology ... cases were…
Research article · 25 Feb 2020 A phase 1 study on midostaurin plus panobinostat in unfit acute myeloid leukemia and high-risk myelodysplastic syndrome
anti-leukemic activity against both FLT3 mutated as well as unmutated Acute Myeloid Leukemia (AML) in early phase studies. Panobinostat, a potent oral pan-acetylase inhibitor had also shown significant ... first…
Conference abstract · 25 Jul 2019 Novel antitumor agent Jerantinine B mediates apoptotic cell death through c-Jun/JNK pathway and ROS in leukaemic cell lines
Statement of the Problem: Acute myeloid leukaemia (AML) is a complex malignancy associated with genetic, epigenetic, and phenotypic heterogeneity. Chemoresistance and relapse are the major challenges in AML treatment…
Conference abstract · 1 Jun 2019 Cancer Nursing 2019: Study of Plasma End statin Level in Patients with Acute Myeloid Leukaemia
interfere with the proangiogenic action of growth factors. Introduction: Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy characterized by the accumulation of immature malignant myeloid cells in the…
Research article · 13 Apr 2017 Serum proteomic spectral characteristics of acute myeloid leukemia and their clinical significance
investigated the differences between the serum proteomic spectral characteristics of acute myeloid leukemia (AML) patients and those of healthy people. We collected peripheral blood serum samples from 62 AML patients…
Conference abstract · 3 Oct 2016 Clinical application of molecular testing in myeloid leukemia
epithelial cancer cells. In this study, we studied Ig expression in acute myeloid leukemia (AML). We found that Ig was expressed at a high frequency and level in AML cell ... flow cytometry. We further assessed…
Conference abstract · 5 Oct 2015 Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia
Background: Acute myeloid leukemia (AML) represents a heterogeneous group of malignancies with great variability in clinical course and response to therapy. Several molecular markers have been described that help…
Commentary · 2015 CD200 Suppresses the Natural Killer Cells and Decreased its Activity in Acute Myeloid Leukemia Patients
Immunosuppression is greatly involved in tumor escape from immune surveillance in acute myeloid leukemia (AML) patients. Being an immunosuppressive molecule, CD200 is upregulated in some hematological malignancies…
Article · 2014 Identification of a Chemoresistant and#8220;Oxidative State-Lowand#8221; Leukemic Subpopulation in CD34+ Human Acute Myeloid Leukemia
levels of reactive oxygen species (ROS), but the redox state in acute myeloid leukemia (AML) has not been thoroughly characterized and the role of ROS in leukemogenesis is still unclear ... report the identification of…
Research article · 2013 Therapeutic Combination of Nanoliposomal Safingol and Nanoliposomal Ceramide for Acute Myeloid Leukemia
ceramide-based therapeutics are of interest for the treatment of acute myeloid leukemia (AML). Ceramide is a bioactive sphingolipid that has long been established as an inducer of apoptosis ... this metabolic pathway…
Research article · 2012 Comprehensive FLT3 analysis in Indian acute myeloid leukaemia
Abstract Aim: Activating mutations of FLT3 are commonly found in AML patients and reported to be associated with poor clinical outcome. We aimed to evaluate the incidence of FLT3 mutations ... along with FLT3 mRNA and…
Conference abstract Clinical applications of immunoglobulin expression in acute myeloid leukemia
epithelial cancer cells. In this study, we studied Ig expression in acute myeloid leukemia (AML). We found that Ig was expressed at a high frequency and level in AML cell ... flow cytometry. We further assessed…
Conference abstract Prognostic significance of DNMT3A mutations in Egyptian patients with acute myeloid leukemia
Background: Acute myeloid leukemia (AML) represents a heterogeneous group of malignancies with great variability in clinical course and response to therapy. Several molecular markers have been described that help…
Conference abstract Clinical applications of immunoglobulin expression in acute myeloid leukemia
epithelial cancer cells. In this study, we studied Ig expression in acute myeloid leukemia (AML). We found that Ig was expressed at a high frequency and level in AML cell ... flow cytometry. We further assessed…
Research article · 24 Jun 2022 Clinical Significance of Flow Cytometry Findings in Brazilian Patients with De Novo Acute Myeloid Leukemia
Cytometry (FC) is an essential method for diagnosis and classification of Acute Myeloid Leukemias (AML), and its extensive use could identify blast cell subpopulations with phenotypes rarely seen in normal ... clinical…
Conference abstract · 20 Jun 2022 A case of cutaneous angiomyolipoma
Angiomyolipoma (AML) is a tumor composed of adipocytes, smooth muscle, and blood vessels, commonly associated with kidney as a solitary mass. Extrarenal AMLs have been reported in liver, nasal cavity ... oral cavity…
Research article · 23 May 2022 Anti-Acute Myelogenous Leukaemia Effect of the Ethanolic Extract of the Indian Rose
cancers in the modern era. Out of all Leukaemia, Acute Myelogenous Leukaemia (AML) is the most notorious. The treatment regime being expensive & toxic has led to a world-wide hunt ... alternate sources of anti-AML…
Short communication · 18 Sep 2020 Deficient regulatory innate lymphoid cells and differential expression of miRNAs in patients with haematological diseases
significance of ILCregs and its associated miRNAs in patients with haematological diseases, such as AML, MDS, AA, has yet to be explored. In this study, we evaluate ILCregs frequency, associated ... miRNA…
Conference abstract · 29 Oct 2018 Breast cancer resistance protein in acute myeloid leukemia: Clinical relevance and prognostic significance
Acute myeloid leukemia (AML) is a genetically heterogeneous clonal disorder characterized by the accumulation of acquired genetic alterations in hematopoietic progenitor cells. The multidrug transporter Breast Cancer…

